Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial

Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial

Janet DuBois,1 Suzanne Bruce,2 Daniel Stewart,3 Steven Kempers,4 Christy Harutunian,5 Terry Boodhoo,5 Amy Weitzenfeld,6 Joan-En Chang-Lin5 1DermResearch, Inc., Austin, TX, USA; 2Suzanne Bruce and Associates, PA, Houston, TX, USA; 3Midwest Center for Dermatology & Cosmetic Surgery, Clinton Townsh...

Full description

Bibliographic Details
Main Authors: DuBois J, Bruce S, Stewart D, Kempers S, Harutunian C, Boodhoo T, Weitzenfeld A, Chang-Lin JE
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
scalp
hair loss
hair growth and development
prostaglandin receptors
Online Access:https://www.dovepress.com/setipiprant-for-androgenetic-alopecia-in-males-results-from-a-randomiz-peer-reviewed-fulltext-article-CCID

Internet

https://www.dovepress.com/setipiprant-for-androgenetic-alopecia-in-males-results-from-a-randomiz-peer-reviewed-fulltext-article-CCID

Similar Items